Ganga Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 7.50 Cr
as on 25-06-2024
- Paid Up Capital ₹ 4.84 Cr
as on 25-06-2024
- Company Age 35 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.18 Cr
as on 25-06-2024
- Satisfied Charges ₹ 12.26 Cr
as on 25-06-2024
- Revenue 4.98%
(FY 2023)
- Profit 3.74%
(FY 2023)
- Ebitda -88.78%
(FY 2023)
- Net Worth 0.73%
(FY 2023)
- Total Assets -0.14%
(FY 2023)
About Ganga Pharmaceuticals
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 539680.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 7.50 Cr and a paid-up capital of Rs 4.84 Cr.
The company currently has active open charges totaling ₹2.18 Cr. The company has closed loans amounting to ₹12.26 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Ganga Pharmaceuticals Ltd India are Anagh Sharma as Cfo, Priti Bhaiya as Company Secretary, and Bharat Sharma as Ceo. Chetan Patel, Srijna Sharma, Bharat Sharma, and Two other members serve as directors at the Company.
- CIN/LLPIN
L99999MH1989PLC053392
- Company No.
053392
- Stock Symbol
BSE : 539680
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
11 Sep 1989
- Date of AGM
16 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Listed
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Ganga Pharmaceuticals Ltd offer?
Ganga Pharmaceuticals Ltd offers a wide range of products and services, including Cosmetics, Hair & Beauty Products, Hair Oil, Ayurvedic Digestive Medicine, Digestive Herbal Capsule & Tablet, Ayurvedic,Herbal Products & Medicine, Ayurvedic Medicine.
Who are the key members and board of directors at Ganga Pharmaceuticals?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anagh Sharma  | CFO | 06-Sep-2018 | Current |
| Priti Bhaiya | Company Secretary | 22-Mar-2016 | Current |
| Bharat Sharma | CEO | 25-Jul-2015 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Chetan Patel | Director | 17-May-2013 | Current |
| Srijna Sharma | Whole-Time Director | 12-Oct-2004 | Current |
| Sanjay Kulkarni | Director | 12-Oct-2004 | Current |
| Sachin Chavan | Director | 17-May-2013 | Current |
Financial Performance of Ganga Pharmaceuticals.
Ganga Pharmaceuticals Ltd, for the financial year ended 2023, experienced modest growth in revenue, with a 4.98% increase. The company also saw a slight improvement in profitability, with a 3.74% increase in profit. The company's net worth moved up by a moderate rise of 0.73%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ganga Pharmaceuticals?
In 2023, Ganga Pharmaceuticals had a promoter holding of 66.71% and a public holding of 33.29%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 14 Dec 2021 | ₹3.45 M | Open |
Others Creation Date: 29 Sep 2021 | ₹0.80 M | Open |
Others Creation Date: 18 Jul 2020 | ₹2.00 M | Open |
How Many Employees Work at Ganga Pharmaceuticals?
Unlock and access historical data on people associated with Ganga Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ganga Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ganga Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
